- Home
- ZNTL vs RMI Comparison
ZNTL vs RMI Comparison
Compare ZNTL & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- RMI
- Stock Information
- Founded
- ZNTL 2014
- RMI 2018
- Country
- ZNTL United States
- RMI United States
- Employees
- ZNTL N/A
- RMI N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- RMI Finance/Investors Services
- Sector
- ZNTL Health Care
- RMI Finance
- Exchange
- ZNTL Nasdaq
- RMI Nasdaq
- Market Cap
- ZNTL 105.8M
- RMI 88.8M
- IPO Year
- ZNTL 2020
- RMI N/A
- Fundamental
- Price
- ZNTL $1.42
- RMI $14.46
- Analyst Decision
- ZNTL Buy
- RMI
- Analyst Count
- ZNTL 6
- RMI 0
- Target Price
- ZNTL $6.53
- RMI N/A
- AVG Volume (30 Days)
- ZNTL 729.8K
- RMI 17.4K
- Earning Date
- ZNTL 11-11-2025
- RMI 01-01-0001
- Dividend Yield
- ZNTL N/A
- RMI 7.28%
- EPS Growth
- ZNTL N/A
- RMI N/A
- EPS
- ZNTL N/A
- RMI N/A
- Revenue
- ZNTL $26,865,000.00
- RMI N/A
- Revenue This Year
- ZNTL N/A
- RMI N/A
- Revenue Next Year
- ZNTL N/A
- RMI N/A
- P/E Ratio
- ZNTL N/A
- RMI N/A
- Revenue Growth
- ZNTL N/A
- RMI N/A
- 52 Week Low
- ZNTL $1.01
- RMI $13.05
- 52 Week High
- ZNTL $4.46
- RMI $17.37
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- RMI 66.86
- Support Level
- ZNTL $1.40
- RMI $14.41
- Resistance Level
- ZNTL $2.02
- RMI $14.60
- Average True Range (ATR)
- ZNTL 0.11
- RMI 0.13
- MACD
- ZNTL -0.05
- RMI 0.06
- Stochastic Oscillator
- ZNTL 4.76
- RMI 77.27
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.